Citius Oncology Inc.
Organization details
- Legal name
- Citius Oncology Inc.
- Former names
- TenX Keane Acquisition
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Cranford
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- September
- Ticker symbol
- CTOR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001851484
- EIN
- 99-4362660
Board of directors
-
Carol Webb · DirectorSince 2024
-
Dennis M. Mcgrath · DirectorSince 2024
-
Eugene Myron Holuka · DirectorSince 2024
-
Joel David Mayersohn · DirectorSince 2024
-
Jonathan Peri · DirectorSince 2026
-
Leonard L. Mazur · Director · Chief Executive OfficerSince 2024
-
Myron Z. Holubiak · Director · SecretarySince 2024
-
Robert Joseph Smith · DirectorSince 2024
-
Suren G. Dutia · DirectorSince 2024
Chief executives
Director election results
Annual meeting of September 29, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
89.1%
-
89.2%
-
89.2%
Board connections
8 of this board's directors also sit on 4 other boards. 2 are in the same sector.
-
Citius Pharmaceuticals Inc. Same sectorvia Carol Webb, Dennis M. Mcgrath, Eugene Myron Holuka, Leonard L. Mazur, Myron Z. Holubiak, Robert Joseph Smith and Suren G. Dutia
- via Leonard L. Mazur
-
DarioHealth Corp. Same sectorvia Dennis M. Mcgrath
- via Joel David Mayersohn
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 19, 2025 | Myron Z. Holubiak Director, Officer (Secretary) | Grant or award | +850,000 | — | — |
| Sep 19, 2025 | Robert Joseph Smith Director | Grant or award | +300,000 | — | — |
| Sep 19, 2025 | Suren G. Dutia Director | Grant or award | +300,000 | — | — |
| Sep 19, 2025 | Dennis M. Mcgrath Director | Grant or award | +300,000 | — | — |
| Sep 19, 2025 | Leonard L. Mazur Director, Officer (Chief Executive Officer) | Grant or award | +1,700,000 | — | — |
| Sep 19, 2025 | Carol Webb Director | Grant or award | +300,000 | — | — |
| Sep 19, 2025 | Czuczman Myron Officer (Chief Medical Officer) | Grant or award | +825,000 | — | — |
| Sep 19, 2025 | Eugene Myron Holuka Director | Grant or award | +300,000 | — | — |
| Sep 19, 2025 | Bartushak Jaime Officer (Chief Financial Officer) | Grant or award | +825,000 | — | — |
| Sep 19, 2025 | Joel David Mayersohn Director | Grant or award | +300,000 | — | — |
| Sep 19, 2025 | Myron Z. Holubiak Director, Officer (Secretary) | Grant or award | +100,000 | — | — |
| Jul 28, 2025 | Joel David Mayersohn Director | Other | +21,228 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Citius Oncology Inc.
Who is the CEO of Citius Oncology Inc.?
Leonard L. Mazur has been Citius Oncology Inc.'s Chief Executive Officer since August 2024.
How many directors are on Citius Oncology Inc.'s board?
Citius Oncology Inc.'s board has 9 directors: Carol Webb, Dennis M. Mcgrath, Eugene Myron Holuka, Joel David Mayersohn, Jonathan Peri, Leonard L. Mazur, Myron Z. Holubiak, Robert Joseph Smith and Suren G. Dutia.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="citius-oncology-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.